Back

Anthracycline cardiotoxicity: looking for new therapeutic approaches targeting cell senescence?

Cardiovascular Research

28 April 2018
Organised by: Logo
Read full article
ESC Journals

Contributors

Shariq Abid
Shariq Abid

Author

Larissa Lipskaia
Larissa Lipskaia

Author

Serge Adnot
Serge Adnot

Author

You may be interested in
thumbnail
Webinar
Exercise, rehabilitation and preventive strategies in cardio-oncology
3 December 2025
thumbnail
Congress Presentation
The senolyitc drug ABT-263 reverses HFpEF-associated inflammation, endothelial inflammation and fibrosis
30 June 2021
thumbnail
Congress Presentation
Epigenetic repression by SAHA leads to cardio-protection in anthracycline-induced long-term cardiotoxicity
20 June 2025
thumbnail
Congress Presentation
Repeated low doses of doxorubicin induce senescence and functional decline in dyn-EHTs which can be rescued using senomorphics.
22 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources